We identify somatically altered genes associated with significantly increased TMB and identify a novel mutation hotspot in the promoter of the PMS2 gene, which is mutated in ~10% of skin cancers and is associated with greatly increased TMB. This evidence concerns the gene PMS2 and skin neoplasm.